{"celex_id": "32013D0301(01)", "uri": "http://publications.europa.eu/resource/cellar/884e08be-8261-11e2-89d6-01aa75ed71a1", "type": "Decision", "concepts": ["2789", "3370", "5916", "8465"], "title": "Commission Decision of 28\u00a0February 2013 appointing members and alternates of the Pharmacovigilance Risk Assessment Committee to represent healthcare professionals and patient organisations  Text with EEA relevance\n", "header": "1.3.2013 EN Official Journal of the European Union C 60/8\nCOMMISSION DECISION\nof 28 February 2013\nappointing members and alternates of the Pharmacovigilance Risk Assessment Committee to represent healthcare professionals and patient organisations\n(Text with EEA relevance)\n2013/C 60/03\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency\u00a0(1), and in particular Article 61a(1) thereof,\nWhereas:\n(1) Article 61a(1) of Regulation (EC) No 726/2004 requires that the Commission appoints representatives of healthcare professionals and patient organisations to the European Medicines Agency Pharmacovigilance Risk Assessment Committee.\n(2) In accordance with Article 61a(1) of Regulation (EC) No 726/2004, a public call for expression of interest has been undertaken by the Commission. The European Parliament has been consulted on the results of the evaluation of the applications received in the framework of this call for expression of interest.\n(3) The members and alternates of the Committee shall be appointed for a period of three years starting on 1 March 2013, which may be prolonged once,", "main_body": ["1.\u00a0\u00a0\u00a0The following are hereby appointed members and alternates of the Pharmacovigilance Risk Assessment Committee to represent healthcare professionals for a term of three years from 1 March 2013:\n\u2014 Member: Filip Babylon,\n\u2014 Alternate: Kirsten Myhr.\n2.\u00a0\u00a0\u00a0The following are hereby appointed members and alternates of the Committee to represent patient organisations for a term of three years from 1 March 2013:\n\u2014 Member: Albert van der Zeijden,\n\u2014 Alternate: Marco Greco."], "attachments": "Done at Brussels, 28 February 2013.\nFor the Commission, On behalf of the President,\nTonio BORG\nMember of the Commission\n(1)\u00a0\u00a0OJ L 136, 30.4.2004, p. 1."}